Wesfarmers shares baulk on fresh acquisition gossip

A healthcare company gone nowhere in a decade might be on Wesfarmers' radar.

| More on:
A female broker in a red jacket whispers in the ear of a man who has a surprised look on his face as she explains which two ASX 200 shares should do well in today's volatile climate

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Wesfarmers Ltd (ASX: WES) share price is treading water today on fresh acquisition rumours.

Shares in the diverse retailing conglomerate are down 0.4% to $65.33. Meanwhile, the S&P/ASX 200 Index (ASX: XJO) is up 0.4%.

After a quiet start to the year, word on the grapevine is Wesfarmers might be preparing for its next acquisition. If the gossip is true, it could be one of the company's largest deals in many years, trumping the $760 million takeover of Australian Pharmaceutical Industries (API) in 2022.

The rumoured $12 billion target

According to The Australian's Dataroom, Wesfarmers has been evaluating the worthiness of scooping up Ramsay Health Care Ltd (ASX: RHC) for months.

Ramsay Health was founded in 1964 by the late Paul Ramsay. What started as a converted house in Sydney is now a fully-fledged hospital and medical clinic operator spread across 11 countries.

Yet, despite the expansive operations, Ramsay's profits and share price remain unchanged from a decade ago.

Always searching for an opportune buy, Wesfarmers could be eyeing Ramsay as the next gem in its expanding healthcare collection. In 2022, the conglomerate acquired API — the company behind Priceline pharmacies. Last year, Silk Laser Clinics was rolled into the Wesfarmers health division.

Whether 'The Wolf of the West' hopes to eat Ramsay Health whole or pick it apart is unknown at this stage.

Ramsay contains a franchise pharmacy network and 40 in-hospital dispensaries throughout Australia. Furthermore, the company launched an online pharmacy in August last year, which might meld well with Wesfarmers' InstantScripts — a consultation and script-filling telehealth platform — acquisition.

What might be a worry for Wesfarmers shares?

Wesfarmers set an Australian corporate record in 2007 when it acquired Coles Group Ltd (ASX: COL) for $19.3 billion. Back then, Wesfarmers had a market capitalisation of about $40 billion.

Eleven years later, Coles had become a formidable competitor to Woolworths Group Ltd (ASX: WOW). But not without Wesfarmers pouring $8 billion into its turnaround. After all the effort (and money), the conglomerate spun Coles off at a valuation of… $20 billion.

Some argue the Coles escapade was a prime example of opportunity cost.

Ramsay Health is a similarly large candidate. At $16 billion, it's roughly 40% of Wesfarmers' size. More importantly, like Coles, Ramsay could risk dragging Wesfarmers' margins downward.

As shown below, the hospital operator achieved a 1.4% margin for the 12 months ended 31 December 2023. That's a far cry from the nearly 6% the Bunnings-owner is netting.

MeasureWesfarmersRamsay Health Care
Revenue$43.7 billion$16.0 billion
Net profit after tax (NPAT)$2.5 billion$220.5 million
Net margin5.7%1.4%
Forward price-to-earnings (P/E) ratio27.7 times22.4 times
Market capitalisation$74.4 billion$11.7 billion
All financials as of 31 December 2023

The Ramsay Health share price is basking in renewed attention today. At the time of writing, shares are fetching $53.00, up 3.8% from yesterday.

Motley Fool contributor Mitchell Lawler has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended Wesfarmers. The Motley Fool Australia has positions in and has recommended Coles Group and Wesfarmers. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Mergers & Acquisitions

A couple stares at the tv in shock, one holding the remote up ready to press.
Mergers & Acquisitions

Telstra share price climbs amid $3.4b Foxtel sale

Who is buying the Foxtel business? Let's find out.

Read more »

two men shake hands on a deal.
Mergers & Acquisitions

Wesfarmers shares lower on $770m asset sale

Let's see which business the conglomerate is offloading.

Read more »

A man sits in deep thought with a pen held to his lips as he ponders his computer screen with a laptop open next to him on his desk in a home office environment.
Real Estate Shares

ASX 200 stock slips on $482 million retail deal

The ASX 200 stock is expanding its retail holdings by almost half a billion dollars.

Read more »

a woman drawing image on wall of big fish about to eat a small fish
Financial Shares

Guess which ASX 200 share just received a $2.68b takeover offer

Private equity firm Bain Capital has its eyes on this financial services company.

Read more »

A senior pharmacist talks to a customer at the counter in a shop
Mergers & Acquisitions

Own Sigma shares? Here's the latest on the Chemist Warehouse merger

One year ago today, the two companies announced plans to merge. We could now be just a few months away…

Read more »

Two CEOs shaking hands on a deal.
Mergers & Acquisitions

2 ASX 200 shares announcing acquisitions today

M&A activity is heating up with two deals announced this morning.

Read more »

businesswoman holds hand out to shake
Mergers & Acquisitions

Is this ASX All Ords stock primed for a takeover offer in 2025?

The ASX All Ords stock could draw the interest of global companies saddled with fading patents.

Read more »

Woman shaking the hand of a man on a deal.
Mergers & Acquisitions

Up 146% in a year, ASX 200 stock marches higher on $950 million acquisition news

The ASX 200 company is expanding its renewable energy footprint.

Read more »